BioGlutide

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameBioGlutide
Drug Alias NameNA-931
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsInsulin-like growth factor I receptor agonists +[4] 
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorInsulin-like growth factor I receptor +[4] 
Therapy Area/IndicationsOverweightWeight LossBody Weight Changes +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomed Industries Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomed Industries Inc
Inactive CompaniesN/A
Active IndicationsOverweightWeight LossBody Weight Changes +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A